Development of an animal model for chronic mild hyperhomocysteinemia and its response to oxidative damage

International Journal of Developmental Neuroscience

Volumn 29, Issue 7, 2011, Pages 693-699

  Scherer, Emilene B S ^a   da Cunha, Aline Andrea ^a   Kolling, Janaína ^a   da Cunha, Maira J ^a   Schmitz, Felipe ^a   Sitta, Angela ^b   Lima, Daniela D ^c   Delwing, Débora ^d   Vargas, Carmem R ^b   Wyse, Angela T S ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^c Universidade Comunitaria Regional de Chapeco   (Brazil)

^d REGIONAL UNIVERSITY OF BLUMENAU   (Brazil)

Author keywords

Animal model; Homocysteine; Mild hyperhomocysteinemia; Oxidative stress

Indexed keywords

ANTIOXIDANT; HOMOCYSTEINE; NITRITE; REACTIVE OXYGEN METABOLITE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD; BLOOD LEVEL; BRAIN CORTEX; BRAIN LEVEL; CONTROLLED STUDY; DISEASE MODEL; EXPERIMENTAL RAT; HYPERHOMOCYSTEINEMIA; MILD HYPERHOMOCYSTEINEMIA; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PUERPERIUM; RAT;

ANIMALS; ANTIOXIDANTS; CATALASE; CEREBRAL CORTEX; DISEASE MODELS, ANIMAL; GLUTATHIONE PEROXIDASE; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; NITRITES; OXIDATION-REDUCTION; OXIDATIVE STRESS; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

ANIMALIA; RATTUS;

EID: 80053576280     PISSN: 07365748     EISSN: 1873474X     Source Type: Journal    
DOI: 10.1016/j.ijdevneu.2011.06.004     Document Type: Article

References (69)

1. Aebi H. Catalase in vitro. Methods Enzymol. 1984, 105:121-126.
2. Alho H., Leinonen J. Total antioxidant activity measured by chemiluminescence methods. Methods Enzymol. 1999, 299:3-15.
3. Blaise S.A., Nédélec E., Schroeder H., Alberto J.M., Bossenmeyer-Pourié C., Guéant J.L., Daval J.L. Gestational vitamin B deficiency leads to homocysteine-associated brain apoptosis and alters neurobehavioral development in rats. Am. J. Pathol. 2007, 170:667-679.
4. Brusque A.M., Mello C.F., Buchanan D.N., Terracciano S.T., Rocha M.P., Vargas C.R., Wannmacher C.M., Wajner M. Effect of chemically induced propionic acidemia on neurobehavioral development of rats. Pharmacol. Biochem. Behav. 1999, 64:529-534.
5. Cakmak S.K., Gül U., Kiliç C., Gönül M., Soylu S., Kiliç A. Homocysteine, vitamin B12 and folic acid levels in psoriasis patients. J. Eur. Acad. Dermatol. Venereol. 2009, 23:300-303.
6. Castro R., Rivera I., Blom H.J., Jakobs C., Tavares de Almeida I. Homocysteine metabolism, hyperhomocysteinaemia and vascular disease: an overview. J. Inherit. Metab. Dis. 2006, 29:3-20.
7. Dayal S., Lentz S.R. ADMA and hyperhomocysteinemia. Vasc. Med. 2005, 10:S27-S33.
8. De Bree A., Verschuren W.M., Kromhout D., Kluijtmans L.A., Blom H.J. Homocysteine determinants and the evidence to what extent homocysteine determines the risk of coronary heart disease. Pharmacol. Rev. 2002, 54:599-618.
9. Doshi S.N., McDowell I.F., Moat S.J., Payne N., Durrant H.J., Lewis M.J., Goodfellow J. Folic acid improves endothelial function in coronary artery disease via mechanisms largely independent of homocysteine lowering. Circulation 2002, 105:22-26.
10. Dutra J.C., Wajner M., Wannmacher C.M., Wannmacher L.E., Pires R.F., Rosa-Júnior A. Effect of postnatal methylmalonate administration on adult rat behavior. Braz. J. Med. Biol. Res. 1991, 24:595-605.
11. Eberhardt R.T., Forgione M.A., Cap A., Leopold J.A., Rudd M.A., Trolliet M., Heydrick S., Stark R., Klings E.S., Moldovan N.I., Yaghoubi M., Goldschmidt-Clermont P.J., Farber H.W., Cohen R., Loscalzo J. Endothelial dysfunction in a murine model of mild hyperhomocyst(e)inemia. J. Clin. Invest. 2000, 106:483-491.
12. Evelson P., Travacio M., Repetto M., Escobar J., Llesuy S., Lissi E.A. Evaluation of total reactive antioxidant potential (TRAP) of tissue homogenates and their cytosols. Arch. Biochem. Biophys. 2001, 388:261-266.
13. Finkelstein J.D. The metabolism of homocysteine: pathways and regulation. Eur. J. Pediatr. 1998, 157:S40-44.
14. Fukada S., Shimada Y., Morita T., Sugiyama K. Suppression of methionine-induced hyperhomocysteinemia by glycine and serine in rats. Biosci. Biotechnol. Biochem. 2006, 70:2403-2409.
15. Green L.C., Wagner D.A., Glogowski J., Skipper P.L., Wishnok J.S., Tannenbaum S.R. Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids. Anal. Biochem. 1982, 126:131-138.
16. Grieve A., Butcher S.P., Griffiths R. Synaptosomal plasma membrane transport of excitatory sulphur amino acid transmitter candidates: kinetic characterisation and analysis of carrier specificity. J. Neurosci. Res. 1992, 32:60-68.
17. Gutteridge J.M.C. Free Radicals in Biology and Medicine 2001, Oxford University Press, New York. fourth ed.
18. Halliwell B. Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment. Drugs Aging 2001, 18:685-916.
19. Halliwell B. Oxidative stress and neurodegeneration: where are we now?. J. Neurochem. 2006, 97:1634-1658.
20. Halliwell B., Gutteridge J.M.C. Free Radicals in Biology and Medicine 2007, Oxford University Press, New York. fourth ed.
21. Hansrani M., Stansby G. The use of an in vivo model to study the effects of hyperhomocysteinaemia on vascular function. J. Surg. Res. 2008, 145:13-18.
22. Huang T., Yuan G., Zhang Z., Zou Z., Li D. Cardiovascular pathogenesis in hyperhomocysteinemia. Asia Pac. J. Clin. Nutr. 2008, 17:8-16.
23. Ignarro L.J., Fukuto J.M., Griscavage J.M., Rogers N.E., Byrns R.E. Oxidation of nitric oxide in aqueous solution to nitrite but not to nitrate: comparison with enzymatically formed nitric oxide from l-arginine. Proc. Natl. Acad. Sci. U.S.A. 1993, 90:8103-8107.
24. Jacques P.F., Bostom A.G., Wilson P.W., Rich S., Rosenberg I.H., Selhub J. Determinants of plasma total homocysteine concentration in the Framingham offspring cohort. Am. J. Clin. Nutr. 2001, 73:613-621.
25. Kado D.M., Karlamangla A.S., Huang M.H., Troen A., Rowe J.W., Selhub J., Seeman T.E. Homocysteine versus the vitamins folate, B6, and B12 as predictors of cognitive function and decline in older high-functioning adults: MacArthur Studies of Successful Aging. Am. J. Med. 2005, 118:161-167.
26. Kim Y.I. Folate and cancer prevention: a new medical application of folate beyond hyperhomocysteinemia and neural tube defects. Nutr. Rev. 1999, 57:314-321.
27. LeBel C.P., Ali S.F., McKee M., Bondy S.C. Organometal-induced increases in oxygen reactive species: the potential of 2',7'-dichlorofluorescein diacetate as an index of neurotoxic damage. Toxicol. Appl. Pharmacol. 1990, 104:17-24.
28. Lee I., Lee H., Kim J.M., Chae E.H., Kim S.J., Chang N. Short-term hyperhomocysteinemia-induced oxidative stress activates retinal glial cells and increases vascular endothelial growth factor expression in rat retina. Biosci. Biotechnol. Biochem. 2007, 71:1203-1210.
29. Lin J., Lee I.M., Song Y., Cook N.R., Selhub J., Manson J.E., Buring J.E., Zhang S.M. Plasma homocysteine and cysteine and risk of breast cancer in women. Cancer Res. 2010, 70:2397-2405.
30. Lissi E., Pascual C., Del Castillo M.D. Luminol luminescence induced by 2,2'-azo-bis-(2-amidinopropane) thermolysis. Free Radic. Res. Commun. 1992, 17:299-311.
31. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951, 193:265-275.
32. Magera M.J., Lacey J.M., Casetta B., Rinaldo P. Method for the determination of total homocysteine in plasma and urine by stable isotope dilution and electrospray tandem mass spectrometry. Clin. Chem. 1999, 45:1517-1522.
33. Manolescu B.N., Oprea E., Farcasanu I.C., Berteanu M., Cercasov C. Homocysteine and vitamin therapy in stroke prevention and treatment: a review. Acta Biochim. Pol. 2010, 57:467-477.
34. Marklund S.L. Pyrogallol autoxidation. Handbook for Oxygen Radical Research 1985, CRC Press, Boca Raton, pp. 243-247.
35. Matés J.M., Pérez-Gomes C., Núnez de Castro I. Antioxidant enzymes and human diseases. Clin. Biochem. 1999, 32:595-603.
36. Matté C., Mackedanz V., Stefanello F.M., Scherer E.B., Andreazza A.C., Zanotto C., Moro A.M., Garcia S.C., Gonçalves C.A., Erdtmann B., Salvador M., Wyse A.T. Chronic hyperhomocysteinemia alters antioxidant defenses and increases DNA damage in brain and blood of rats: protective effect of folic acid. Neurochem. Int. 2009, 54:7-13.
37. +-ATPase activity in parietal, prefrontal and cingulate cortex of young rats. Int. J. Dev. Neurosci. 2004, 22:185-190.
38. Mattson M.P., Shea T.B. Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders. Trends Neurosci. 2003, 26:137-146.
39. Moreira J.C., Wannmacher C.M.D., Costa S.M., Wajner M. Effect of proline administration on rat behavior in aversive and nonaversive tasks. Pharmacol. Biochem. Behav. 1989, 32:885-890.
40. Murawska-Cialowicz E., Januszewska L., Zuwala-Jagiello J., Milczarska J., Zawadzki M., Paprocka-Borowicz M., Wierzbicka-Damska I. Melatonin decreases homocysteine level in blood of rats. J. Physiol. Pharmacol. 2008, 59:717-729.
41. Nediani C., Raimondi L., Borchi E., Cerbai E. Nitric oxide/reactive oxygen species generation and nitroso/redox imbalance in heart failure: from molecular mechanisms to therapeutic implications. Antioxid. Redox Signal. 2010, 14:289-331.
42. Nishio E., Watanabe Y. Homocysteine as a modulator of platelet-derived growth factor action in vascular smooth muscle cells: a possible role for hydrogen peroxide. Br. J. Pharmacol. 1997, 122:269-274.
43. Obeid R., Herrmann W. Mechanisms of homocysteine neurotoxicity in neurodegenerative diseases with special reference to dementia. FEBS Lett. 2006, 580:2994-3005.
44. Ohkawa H., Ohishi N., Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 1979, 95:351-358.
45. Perna A.F., Ingrosso D., Galletti P., Zappia V., De Santo N.G. Membrane protein damage and methylation reactions in chronic renal failure. Kidney Int. 1996, 50:358-366.
46. Selhub J. The many facets of hyperhomocysteinemia: studies from the Framingham cohorts. J. Nutr. 2006, 136:S1726-S1730.
47. Sharma M., Rai S.K., Tiwari R.K., Tiwari M., Chandra R. Effects of nitric oxide modulators on cardiovascular risk factors in mild hyperhomocysteinaemic rat model. Basic Clin. Pharmacol. Toxicol. 2008, 103:25-30.
48. Sharma P., Senthilkumar R.D., Brahmachari V., Sundaramoorthy E., Mahajan A., Sharma A., Sengupta S. Mining literature for a comprehensive pathway analysis: a case study for retrieval of homocysteine related genes for genetic and epigenetic studies. Lipids Health Dis. 2006, 5:1-19.
49. Stamler J.S., Osborne J.A., Jaraki O., Rabbani L.E., Mullins M., Singel D., Loscalzo J. Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. J. Clin. Invest. 1993, 91:308-318.
50. Steegers-Theunissen R.P., Boers G.H., Trijbels F.J., Finkelstein J.D., Blom H.J., Thomas C.M., Borm G.F., Wouters M.G., Eskes T.K. Maternal hyperhomocysteinemia: a risk factor for neural-tube defects?. Metabolism 1994, 43:1475-1480.
51. Stefanello F.M., Matté C., Scherer E.B., Wannmacher C.M., Wajner M., Wyse A.T. Chemically induced model of hypermethioninemia in rats. J. Neurosci. Methods 2007, 160:1-4.
52. +-ATPase activity in hippocampus of rats subjected to chemically induced hyperhomocysteinemia. Neurochem. Res. 2002, 27:1593-1598.
53. Tessari P., Coracina A., Kiwanuka E., Vedovato M., Vettore M., Valerio A., Zaramella M., Garibotto G. Effects of insulin on methionine and homocysteine kinetics in type 2 diabetes with nephropathy. Diabetes 2005, 54:2968-2976.
54. Troen A.M., Lutgens E., Smith D.E., Rosenberg I.H., Selhub J. The atherogenic effect of excess methionine intake. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:15089-15094.
55. Troen A.M., Shea-Budgell M., Shukitt-Hale B., Smith D.E., Selhub J., Rosenberg I.H. B-vitamin deficiency causes hyperhomocysteinemia and vascular cognitive impairment in mice. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:12474-12479.
56. Tyagi N., Moshal K.S., Ovechkin A.V., Rodriguez W., Steed M., Henderson B., Roberts A.M., Joshua I.G., Tyagi S.C. Mitochondrial mechanism of oxidative stress and systemic hypertension in hyperhomocysteinemia. J. Cell. Biochem. 2005, 96:665-671.
57. Tyagi N., Sedoris K.C., Steed M., Ovechkin A.V., Moshal K.S., Tyagi S.C. Mechanisms of homocysteine-induced oxidative stress. Am. J. Physiol. Heart Circ. Physiol. 2005, 289:H2649-H2656.
58. Tyagi S.C. Homocystine redox receptor and regulation of extracellular matrix components in vascular cells. Am. J. Physiol. 1998, 274:C396-C405.
59. Ungvari Z., Csiszar A., Edwards J.G., Kaminski P.M., Wolin M.S., Kaley G., Koller A. Increased superoxide production in coronary arteries in hyperhomocysteinemia: role of TNF, NAD(P)H oxidase and iNOS. Arterioscler. Thromb. Vasc. Biol. 2003, 23:418-424.
60. Upchurch G.R., Welch G.N., Fabian A.J., Freedman J.E., Johnson J.L., Keaney J.F., Loscalzo J. Homocyst(e)ine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase. J. Biol. Chem. 1997, 272:17012-17017.
61. Valko M., Rhodes C.J., Moncol J., Izakovic M., Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem. Biol. Interact. 2006, 160:1-40.
62. Ventura E., Durant R., Jaussent A., Picot M.C., Morena M., Badiou S., Dupuy A.M., Jeandel C., Cristol J.P. Homocysteine and inflammation as main determinants of oxidative stress in the elderly. Free Radic. Biol. Med. 2009, 46:737-744.
63. Welch G.N., Upchurch G.R., Farivar R.S., Pigazzi A., Vu K., Brecher P., Keaney J.F., Loscalzo J. Homocysteine-induced nitric oxide production in vascular smooth-muscle cells by NF-kappaB-dependent transcriptional activation of Nos2. Proc. Assoc. Am. Physic. 1998, 110:22-31.
64. Wendel A. Glutathione peroxidase. Methods Enzymol. 1981, 77:325-333.
65. Williams K.T., Schalinske K.L. Homocysteine metabolism and its relation to health and disease. Biofactors 2010, 36:19-24.
66. Wyse A.T., Sarkis J.J., Cunha-Filho J.S., Teixeira M.V., Schetinger M.R., Wajner M., Milton C., Wannmacher D. Effect of phenylalanine and its metabolites on ATP diphosphohydrolase activity in synaptosomes from rat cerebral cortex. Neurochem. Res. 1994, 19:1175-1180.
67. Wyse A.T., Sarkis J.J., Cunha-Filho J.S., Teixeira M.V., Schetinger M.R., Wajner M., Wannmacher C.M. ATP diphosphohydrolase activity in synaptosomes from cerebral cortex of rats subjected to chemically induced phenylketonuria. Braz. J. Med. Biol. Res. 1995, 28:643-649.
68. Yamamato M., Hara H., Adachi T. Effects of homocysteine on the binding of extracellular-superoxide dismutase to the endothelial cell surface. FEBS Lett. 2000, 486:159-162.
69. Zhang X., Li H., Jin H., Ebin Z., Brodsky S., Goligorsky M.S. Effects of homocysteine on endothelial nitric oxide production. Am. J. Physiol. Renal Physiol. 2000, 279:F671-678.